BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Diabetes and Endocrinology - Immunology - Physiology - Rheumatology

IGF-1 and PDGF-bb Suppress IL-1ß-Induced Cartilage Degradation through Down-Regulation of NF-?B Signaling: Involvement of Src/PI-3K/AKT Pathway
Published: Wednesday, December 14, 2011
Author: Azadeh Montaseri et al.

by Azadeh Montaseri, Franziska Busch, Ali Mobasheri, Constanze Buhrmann, Constance Aldinger, Jafar Soleimani Rad, Mehdi Shakibaei

Objective

Interleukin-1ß (IL-1ß) is a pro-inflammatory cytokine that plays a key role in the pathogenesis of osteoarthritis (OA). Growth factors (GFs) capable of antagonizing the catabolic actions of cytokines may have therapeutic potential in the treatment of OA. Herein, we investigated the potential synergistic effects of insulin-like growth factor (IGF-1) and platelet-derived growth factor (PDGF-bb) on different mechanisms participating in IL-1ß-induced activation of nuclear transcription factor-?B (NF-?B) and apoptosis in chondrocytes.

Methods

Primary chondrocytes were treated with IL-1ß to induce dedifferentiation and co-treated with either IGF-1 or/and PDGF-bb and evaluated by immunoblotting and electron microscopy.

Results

Pretreatment of chondrocytes with IGF-1 or/and PDGF-bb suppressed IL-1ß-induced NF-?B activation via inhibition of I?B-a kinase. Inhibition of I?B-a kinase by GFs led to the suppression of I?B-a phosphorylation and degradation, p65 nuclear translocation and NF-?B-regulated gene products involved in inflammation and cartilage degradation (COX-2, MMPs) and apoptosis (caspase-3). GFs or BMS-345541 (specific inhibitor of the IKK) reversed the IL-1ß-induced down-regulation of collagen type II, cartilage specific proteoglycans, ß1-integrin, Shc, activated MAPKinase, Sox-9 and up-regulation of active caspase-3. Furthermore, the inhibitory effects of IGF-1 or/and PDGF-bb on IL-1ß-induced NF-?B activation were sensitive to inhibitors of Src (PP1), PI-3K (wortmannin) and Akt (SH-5), suggesting that the pathway consisting of non-receptor tyrosine kinase (Src), phosphatidylinositol 3-kinase and protein kinase B must be involved in IL-1ß signaling.

Conclusion

The results presented suggest that IGF-1 and PDGF-bb are potent inhibitors of IL-1ß-mediated activation of NF-?B and apoptosis in chondrocytes, may be mediated in part through suppression of Src/PI-3K/AKT pathway, which may contribute to their anti-inflammatory effects.

  More...